Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

Press Release/Announcement

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

Bethesda, MD: Food and Drug Administration; August 16, 2021.

Lack of standardization in processes, devices, and colors contributes to errors and patient harm. This letter to industry calls for medical device manufactures to use standard colors for patient identification wristbands to minimize confusion regarding do-not-resuscitate status.

Free full text

Related information

Related Resources From the Same Author(s)

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

Safety Problems With Your Child's Medical Device?

July 31, 2013

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

October 21, 2009

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

New AHRQ SOPS® Workplace Safety Supplemental Items for Hospitals.

December 16, 2021 - December 16, 2021

Strategic Plan for Preventing and Mitigating Drug Shortages.

November 13, 2013

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health.

June 6, 2018

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

EPINEPHrine pre-filled syringe shortage.

June 30, 2010

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

A Review of FDA’s Approach to Medical Product Shortages.

November 16, 2011

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

March 22, 2006

Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry.

January 9, 2013

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

FDA Pharmacists Help Consumers Use Medicines Safely.

November 19, 2014

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

Making Medical Devices Safer at Home.

January 9, 2013

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

Relenza (zanamivir) inhalation powder.

October 21, 2009

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

October 7, 2009

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

January 25, 2017

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

February 20, 2008

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

July 26, 2006

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

March 26, 2008

Five Medication Safety Tips for Older Adults.

February 15, 2024

Health Policy Brief: Improving Quality and Safety.

May 18, 2011

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

ASHP IV Adult Continuous Infusions.

January 18, 2017

Partnering with Patients and Families to Enhance Safety and Quality: A Mini Toolkit.

December 7, 2011

Wear face masks with no metal during MRI exams.

December 16, 2020

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Strategically Advancing Patient and Family Advisory Councils in New York State Hospitals.

September 12, 2018

Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors.

January 13, 2016

FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).

June 3, 2015

Shelhigh, Inc. implantable medical devices.

May 2, 2007

Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed).

March 22, 2023

FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change.

January 9, 2005

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

Teaching Kids About Using Medicine Safely.

February 29, 2012

BeSafeRx: Know Your Online Pharmacy.

October 10, 2012

Lock it Up: Medicine Safety in Your Home.

November 30, 2011

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Be an Active Member of Your Health Care Team.

May 21, 2014

OpenFDA.

June 11, 2014

FDA MedWatch and Patient Safety Tutorial.

December 10, 2008

FDA Patient Safety News. A Video News Show for Health Professionals.

March 6, 2005

The pros and cons of EHR clinical decision support alerts.

April 28, 2021

10 Leadership mindsets for high reliability organizations. How to empower caregivers and engage patients in patient safety.

April 14, 2021

When we're all responsible for a patient's death, no one is.

November 24, 2021

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

September 29, 2010

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

MedWatch E-list.

March 6, 2005

Postmarket Drug Safety Information for Patients and Providers.

November 19, 2008

FDA public health notification: unretrieved device fragments.

January 30, 2008

Age-related COVID-19 vaccine mix-ups.

December 15, 2021

Promethazine HCl (marketed as Phenergan) Information.

May 3, 2006

Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine.

February 22, 2006

Medicines in My Home.

August 2, 2006

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

June 7, 2006

My Medicines.

July 9, 2014

Medication Safety Officer's Handbook.

July 23, 2014

Medication Safety: A Guide for Health Care Facilities.

July 20, 2005

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry.

December 23, 2020

Partnering with Patients and Families to Design a Patient- and Family-Centered Health Care System: Recommendations and Promising Practices.

June 4, 2008

FDA 101: How to Use the Consumer Complaint System and MedWatch.

June 25, 2008

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

SmartTots.

April 13, 2011

Interference between CT and Electronic Medical Devices.

July 30, 2008

Related Resources

Common Formats for Patient Safety Data Collection.

March 13, 2024

Systems-Based Approaches to Improve Patient Safety by Improving Healthcare Worker Safety and Well-Being (R01 Clinical Trial Optional).

December 20, 2023

Challenge Competition: Impact of Patient Safety Tools.

December 12, 2023

Medication guides: patient medication information. A proposed rule by the Food and Drug Administration.

June 28, 2023

Examples of Medical Device Misconnections.

March 8, 2023

The National Healthcare System Action Alliance for Patient and Workforce Safety.

November 14, 2022 - November 14, 2022

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff.

October 3, 2022

Agency Information Collection Activities: Proposed Collection; Comment Request, "Hospital Survey on Patient Safety Culture Comparative Database.''

June 22, 2022

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

COVID-19 Focused Inspection Initiative in Healthcare.

March 23, 2022

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Agency information collection activities: National Healthcare Safety Network (NHSN); comment request.

October 13, 2021

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Wear face masks with no metal during MRI exams.

December 16, 2020

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

See More About The Topic

Hospitals

Health Care Executives and Administrators

Engineers

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site